Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Mallinckrodt
Harvard Business School
Merck
Express Scripts

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Brincidofovir

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Brincidofovir?

Brincidofovir is an investigational drug.

There have been 10 clinical trials for Brincidofovir. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2013.

The most common disease conditions in clinical trials are Adenoviridae Infections, Viremia, and Cytomegalovirus Infections. The leading clinical trial sponsors are Chimerix and [disabled in preview].

There are seven US patents protecting this investigational drug and seventy-eight international patents.

Recent Clinical Trials for Brincidofovir
TitleSponsorPhase
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus ViremiaChimerixPhase 2
The AdAPT Trial; Adenovirus After Allogeneic Pediatric TransplantationChimerixPhase 2
SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCVChimerixPhase 3

See all Brincidofovir clinical trials

Clinical Trial Summary for Brincidofovir

Top disease conditions for Brincidofovir
Top clinical trial sponsors for Brincidofovir

See all Brincidofovir clinical trials

US Patents for Brincidofovir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Brincidofovir   Start Trial Phosphonate ester derivatives and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Compounds, compositions and methods for treating ocular conditions Chimerix, Inc. (Durham, NC)   Start Trial
Brincidofovir   Start Trial Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chimerix, Inc. (Durham, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Merck
Dow
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.